文献速递白血病淋巴瘤

NOTCH1激活对慢性淋巴细胞白血病维奈克拉敏感性的潜在影响:体外研究启示与临床意义

Potential impact of NOTCH1 activation on venetoclax sensitivity in chronic lymphocytic Leukaemia: In vitro insights and clinical implications.
PubMed 文献 · Br J Haematol · 2024-06-21

本研究探讨NOTCH1信号激活对慢性淋巴细胞白血病(CLL)细胞维奈克拉敏感性的体外影响。NOTCH1激活仅轻微降低CLL细胞对维奈克拉的敏感性,但体外细胞竞争实验显示,在持续维奈克拉暴露下,组成性NOTCH1激活的细胞生长超过野生型对照细胞。提示NOTCH1激活不足以直接导致维奈克拉耐药,但可能增强细胞逃逸并最终完全耐药的潜能。

要点

  • NOTCH1激活仅轻微降低CLL细胞对维奈克拉的敏感性。
  • 持续维奈克拉暴露下,NOTCH1激活细胞竞争性生长超过野生型细胞。
  • NOTCH1激活可能增强CLL细胞逃逸维奈克拉并最终完全耐药的潜能。

核心结论

  • NOTCH1激活不足以直接导致维奈克拉耐药,但增强CLL细胞逃逸并最终完全耐药的潜能。

研究设计与样本

  • 体外研究,探讨NOTCH1信号激活对CLL细胞维奈克拉敏感性的影响。

主要发现

  • NOTCH1激活仅轻微降低CLL细胞对维奈克拉的敏感性。
  • 体外细胞竞争实验中,持续维奈克拉暴露下组成性NOTCH1激活的CLL细胞生长超过野生型对照细胞。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite significant progress in treating chronic lymphocytic leukaemia (CLL), resistance to therapy remains challenging. NOTCH1 activation, common in CLL, confers adverse prognosis. This study explores the impact of NOTCH1 signalling on venetoclax sensitivity in vitro. Although NOTCH1 activation minimally impaired the susceptibility of CLL cells to venetoclax, ex vivo cell competition studies reveal that cells with constitutive NOTCH1 activation outgrew their wild-type counterparts in the presence of ongoing venetoclax exposure. Our findings suggest that while NOTCH1 activation is insufficient to confer venetoclax refractoriness, there is enhanced potential for cells with NOTCH1 activation to escape and thus become fully resistant to venetoclax.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Gao MY, Georgiou A, Lin VS, et al. Potential impact of NOTCH1 activation on venetoclax sensitivity in chronic lymphocytic Leukaemia: In vitro insights and clinical implications. Br J Haematol. 2024. PMID: 39031781. doi:10.1111/bjh.19604

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。